RIVASTIGMINE GenPar PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Aktivni sastojci:

rivastigmine, Quantity: 27 mg

Dostupno od:

Arrotex Pharmaceuticals Pty Ltd

INN (International ime):

Rivastigmine

Farmaceutski oblik:

Drug delivery system, transdermal

Sastav:

Excipient Ingredients: acrylates copolymer; ethyl acetate; hexane; 2-ethylhexyl acrylate; methyl acrylate; acrylic acid; acrylates/ethylhexyl acrylate copolymer; methylated trimethylated silica

Administracija rute:

Transdermal

Jedinice u paketu:

7 sachets, 30 sachets

Tip recepta:

(S4) Prescription Only Medicine

Terapijske indikacije:

RIVASTIGMINE GENPAR PATCH is indicated for the treatment of patients with mild, moderate and severe dementia of the Alzheimer?s type.

Proizvod sažetak:

Visual Identification: Circular 15cm2 transdermal patch, tri-layer adhesive matrix, translucent white backing film labelled with "Rivastigmine 13.3 mg/24 h"; Container Type: Sachet; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Status autorizacije:

Licence status A

Datum autorizacije:

2017-01-25